NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Instruments & Supplies · USD

Alcon Inc. (ALC) Stock Analysis

Alcon Inc. (ALC) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

ALC

$70.50

−$1.58 (−2.19%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ALC with… →

ALC Key Statistics

As of Sep 4, 2026
Trading
Open
$70.89
Previous Close
$72.08
Day's Range
70.48–71.14
52-Week Range
61.84–87.64
Volume
1.34M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.70
Valuation
Market Cap
$34.08B
P/E Ratio
55.08
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
17.72
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.26
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.14
EPS (ttm)Profit attributable to each share over the last twelve months.
1.28
Financials (FY)
Revenue (FY)
$10.40B+4.94%
Net Income (FY)
$980.00M−3.73%
Profit marginThe share of revenue left as profit after all costs and taxes.
5.92%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
483.40M
1-Year Return
−10.22%
Dividend and dates
Dividend
$0.36+0.50%
Ex-Dividend Date
May 6, 2026
Earnings Date
November 10, 2026
Avg Volume
1.90M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ALC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−10.11%
2025−6.84%
2024+9.02%
2023+14.32%
2022−21.09%
2021+32.23%
2020+16.63%
2019 (partial year)−2.53%

As of September 4, 2026.

ALC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$10.40B$980.00M9.4%
2024$9.91B$1.02B10.3%
2023$9.46B$974.00M10.3%
2022$8.72B$335.00M3.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$10.40B$5.75B$1.36B$980.00M9.4%
2024$9.91B$5.51B$1.41B$1.02B10.3%
2023$9.46B$5.25B$1.04B$974.00M10.3%
2022$8.72B$4.75B$672.00M$335.00M3.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ALC Dividend History

$0.33+25.4% vs 2024

Dividends per share, 2025 · 1 payments

YearDividends per sharePaymentsChange
2026*$0.361—
2025$0.331+25.4%
2024$0.261+11.9%
2023$0.241+15.1%
YearDividends per sharePaymentsChange
2026 (partial year)$0.361—
2025$0.331+25.4%
2024$0.261+11.9%
2023$0.241+15.1%
2022$0.211+86.4%
2021$0.111—

Most recent payment: $0.36 per share, ex-dividend May 5, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

ALC Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricALCMedical Instruments & Supplies medianvs median
P/E55.0835.6155% above
P/S ratio3.143.171% below
Profit margin5.92%0.85%5.1 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 14 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Alcon Inc. (ALC) carries a market capitalisation of $34.08B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. The company reports 25,000 employees.

The 52-week range on file runs from $61.84 to $87.64. ALC last closed at $70.50 on September 4, 2026. That is −$1.58 (−2.19%) against the previous close. The latest close sits 14.01% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $10.40B. That is +4.94% against the prior fiscal year, when revenue was $9.91B. The same year closed with net income of $980.00M. That is −3.73% against the prior fiscal year. Profit margin runs at 5.92%. That is 5.1 percentage points above the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to 1.28.

Across the 4 fiscal years on file, revenue moves from $8.72B in 2022 to $10.40B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 55.08. That is 54.65% above the Medical Instruments & Supplies median of 35.61. The forward P/E on file is 17.72. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.26. Measured against sales, the shares trade at 3.14 times revenue. On price-to-sales that is 1.1% below the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −10.22%. Measured over 5 years, that is −3.23% a year compounded. Beta against the wider market is reported at 0.7. Daily returns over the trailing 7 years annualize to a volatility of 28.14%.

Growth & Income

The trailing dividend yield is 0.5%. That is 0.5 percentage points below the Medical Instruments & Supplies median yield of 0.97%. At the indicated rate that is $0.36 a share a year. The ex-dividend date on file is May 6, 2026. Dividends are recorded for 6 calendar years; 2026 shows 1 payments totalling $0.36 a share. The year before, 2025, totalled $0.33 a share.

2026 is still running; the price is −10.11% year to date. Across the complete calendar years on file, 2021 returned +32.23% and 2022 returned −21.09%. Of the 6 complete calendar years on file, 4 finished higher.

Peer Comparison

Alcon Inc. (ALC) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Alcon Inc. ALC $34.08B 55.1
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Alcon Inc. trades at a P/E of 55.1.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B

 HOLX

Hologic, Inc.

$16.97B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Visit website →